(Q43846856)

27 November 2017

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells (English)

1 reference

27 November 2017

1 reference

Saleh Abu-Raya

1

1 reference

27 November 2017

Rinat Tabakman

2

1 reference

27 November 2017

Eran Blaugrund

3

1 reference

27 November 2017

Victoria Trembovler

4

1 reference

27 November 2017

Philip Lazarovici

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

European Journal of Pharmacology

27 November 2017

1 reference

27 November 2017

434

1 reference

27 November 2017

3

1 reference

27 November 2017

109-116

1 reference

A tissue culture ischemic device to study eicosanoid release by pheochromocytoma PC12 cultures

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Growth factors protect PC12 cells against ischemia by a mechanism that is independent of PKA, PKC, and protein synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Gangliosides rescue neuronal cells from death after trophic factor deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Role for protein synthesis in the neurotoxic effects of methamphetamine in mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Release of dopamine and norepinephrine by hypoxia from PC-12 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Selegiline treatment after transient global ischemia in gerbils enhances the survival of CA1 pyramidal cells in the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Nerve growth factor and K-252a increase catecholamine release from PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

(-)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neuron degeneration mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Effect of deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Cell cycle-specific action of nerve growth factor in PC12 cells: differentiation without proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Hypoxia evokes catecholamine secretion from rat pheochromocytoma PC-12 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Prevention of PC12 cell death by N-acetylcysteine requires activation of the Ras pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

inferred from DOI database lookup

7 January 2021

based on heuristic

(R)(+)-N-propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901548-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01548-5

1 reference

27 November 2017

1 reference